Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Autoimmune Disorders

Free Subscription 09.02.2026 4 BMC Neurol 1 Brain 5 Diabet Med 5 Diabetes Res Clin Pract 3 Intern Med 1 J Autoimmun 2 J Clin Endocrinol Metab 1 J Neuroimmunol 3 J Neurol 3 J Rheumatol 2 Mult Scler 2 Neurology 5 PLoS One 3 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Neurol

1. NIU Z, Sun Y, Li F, Wang Z, et al
   Prominent urinary dysfunction and delayed antibody detection in patients with glial fibrillary acidic protein astrocytopathy: a case series analysis.
   BMC Neurol. 2026;26:63.
   PubMed         Abstract available
   
   
2. SHAH R, Samal S
   Augmented reality assisted physiotherapy rehabilitation in early phase of guillain barre syndrome (AIDP)-a case report.
   BMC Neurol. 2026 Feb 2. doi: 10.1186/s12883-026-04672.
   PubMed         Abstract available
   
   
3. LAPEVANDANI MM, Khodadadi S, Naghitehrani KH, Ayoubi S, et al
   Risk factors affecting the age at onset in adult patients with multiple sclerosis.
   BMC Neurol. 2026 Jan 30. doi: 10.1186/s12883-025-04607.
   PubMed        
   
   
4. KUWASHIGE H, Sugiyama A, Aoyama S, Handa H, et al
   Inferior olive lesions in autoimmune glial fibrillary acidic protein astrocytopathy: a report of two cases.
   BMC Neurol. 2026 Jan 31. doi: 10.1186/s12883-026-04683.
   PubMed        
   
   

   
   Brain

5. MURARO PA, De Matteis E, Scalfari A
   A tight match: comparing the effectiveness of immune reconstitution therapies for multiple sclerosis.
   Brain. 2026 Feb 3:awag044. doi: 10.1093.
   PubMed        
   
   

   
   Diabet Med

6. HOUSBY H, Kaur A, Wylie T, Oliver N, et al
   'They use the little information they have to pass judgement': A framework analysis of type 1 diabetes stigma experienced by UK adults living with type 1 diabetes.
   Diabet Med. 2025 Dec 13:e70191. doi: 10.1111/dme.70191.
   PubMed         Abstract available
   
   
7. CHAHAL T, Alexandre-Heymann L, Yardley JE, Grou C, et al
   Automated insulin delivery system use and physical activity levels in adults with type 1 diabetes: A BETTER registry analysis.
   Diabet Med. 2025 Dec 13:e70192. doi: 10.1111/dme.70192.
   PubMed         Abstract available
   
   
8. PENA D, Medina Penaranda R, Figg LE, Hood KK, et al
   "The pump is one thing... but you should walk out of the hospital with a [sensor]": Perceptions on diabetes technology from minoritized caregivers in the US.
   Diabet Med. 2025 Dec 10:e70189. doi: 10.1111/dme.70189.
   PubMed         Abstract available
   
   
9. RICKARD X, Longfield MSG, Zhou J, Ibiebele I, et al
   The impact of obesity on pregnancy outcomes in women with type 1 and type 2 diabetes across the NSW population: A retrospective cohort study.
   Diabet Med. 2025 Dec 3:e70177. doi: 10.1111/dme.70177.
   PubMed         Abstract available
   
   
10. MAJSTOROVIC M, McGorm KJ, Wentworth JM, Couper JJ, et al
    Knowledge about paediatric screening and monitoring of early-stage type 1 diabetes: A qualitative exploration of healthcare professionals' perspectives and experiences.
    Diabet Med. 2025 Nov 24:e70178. doi: 10.1111/dme.70178.
    PubMed         Abstract available
    
    

    
    Diabetes Res Clin Pract

11. MARTINEZ-MATEU C, Duperval R, Kaminska-Jackowiak O, Al-Abdulrazzaq D, et al
    Comparison of demographics and treatment outcome in children with type 1 diabetes related to the economic background of their country of residence: observations from the SWEET database.
    Diabetes Res Clin Pract. 2026;232:113065.
    PubMed         Abstract available
    
    
12. KADIYALA N, Allen J, Lakshman R, Boughton CK, et al
    Lived experience of fully closed-loop insulin delivery in adolescents with type 1 diabetes and HbA1c above target.
    Diabetes Res Clin Pract. 2026;232:113078.
    PubMed         Abstract available
    
    
13. KYLAHEIKO I, Tarkkonen A, Kuusela L, Martola J, et al
    Cerebral microbleeds are associated with deficits in cognitive processing speed and executive functions in middle-aged adults with type 1 diabetes.
    Diabetes Res Clin Pract. 2026;232:113080.
    PubMed         Abstract available
    
    
14. GRIFFIN TP, Hagan J, Chauhan R, Crabtree TS, et al
    The results of ProHCL: Patient-reported outcomes in people living with type 1 diabetes on hybrid closed-loop insulin pump therapy - experiences from the NHS England pilot.
    Diabetes Res Clin Pract. 2026;232:113084.
    PubMed         Abstract available
    
    
15. DESHPANDE-JOSHI SS, Wagle-Patki SS, Deshmukh MK, Lubree HG, et al
    Neonatal adiposity is predominantly influenced by maternal hyperglycemia than obesity: Evidence from India.
    Diabetes Res Clin Pract. 2026;232:113110.
    PubMed         Abstract available
    
    

    
    Intern Med

16. TANIGUCHI N, Sakai M, Masuda T, Otsuki C, et al
    Urinary beta2-microglobulin as a Potential Biomarker for Early Treatment Selection: A Patient with Severe IgG4-related Tubulointerstitial Nephritis.
    Intern Med. 2026;65:457-463.
    PubMed         Abstract available
    
    
17. SAIGUSA S, Uchino K, Seki H, Sugita Y, et al
    Thyroid Storm Following Alemtuzumab-based Allogeneic Stem Cell Transplantation: A Case Report and Literature Review.
    Intern Med. 2026;65:479-484.
    PubMed         Abstract available
    
    
18. GOTO A, Yoshida M, Murai R, Horiguchi H, et al
    Warm Autoimmune Hemolytic Anemia Associated with Pancreatic Adenocarcinoma Showing Ectopic Expression of Band 3 Protein: A Case Report.
    Intern Med. 2026 Feb 1. doi: 10.2169/internalmedicine.6765.
    PubMed         Abstract available
    
    

    
    J Autoimmun

19. VAN PUIJFELIK F, Kuiper KL, Rip J, Smolders J, et al
    What's in a name? - juxtaposing T follicular, peripheral and resident helper cells in B cell-driven autoimmune diseases.
    J Autoimmun. 2026;159:103535.
    PubMed         Abstract available
    
    

    
    J Clin Endocrinol Metab

20. LANZOLLA G, Saba F, Corrias S, Lixi F, et al
    Subclinical Ocular Alterations in Graves' Disease: The FUMO Score, a New Tool to Predict Graves' Orbitopathy Progression.
    J Clin Endocrinol Metab. 2026 Feb 2:dgag037. doi: 10.1210.
    PubMed         Abstract available
    
    
21. ANDERSEN SL, Torp NMU, Vestergaard P, Andersen S, et al
    Hyperthyroidism and birth defects: The roles of maternal thyroid function and thyroid autoantibody positivity.
    J Clin Endocrinol Metab. 2026 Feb 4:dgag046. doi: 10.1210.
    PubMed         Abstract available
    
    

    
    J Neuroimmunol

22. TANAKA K, Uzawa A, Yasuda M, Onishi Y, et al
    Serum from patients with acetylcholine receptor antibody-positive myasthenia gravis triggers pathogenic changes in human myotube cells.
    J Neuroimmunol. 2026;413:578871.
    PubMed         Abstract available
    
    

    
    J Neurol

23. SAJIN V, Bohringer MP, Ebert J, Wandinger KP, et al
    A patient with anti-IgLON5 disease associated with cerebral hemorrhage, multiple ischemic strokes, and kidney failure: case report.
    J Neurol. 2026;273:116.
    PubMed         Abstract available
    
    
24. SOUISSI A, Patti F, Spelman T, Chisari C, et al
    Effect of late-onset on multiple sclerosis phenotype and outcome: evidence from a multi-national registry.
    J Neurol. 2026;273:114.
    PubMed         Abstract available
    
    
25. MARGONI M, Gueye M, Meani A, Pagani E, et al
    Substrates of 8.5-year clinical outcomes in aquaporin-4 IgG-positive neuromyelitis optica spectrum disorders.
    J Neurol. 2026;273:112.
    PubMed         Abstract available
    
    

    
    J Rheumatol

26. TSAI Z, Huber AM, Oen K, Proulx-Gauthier JP, et al
    Effect of Treatment Changes on Health-Related Quality of Life in Canadian Children With Juvenile Idiopathic Arthritis: Results From ReACCh-Out and CAPRI.
    J Rheumatol. 2026;53:186-193.
    PubMed         Abstract available
    
    
27. KIM K, Claybaugh D, Patino-Martinez E, Temesgen-Oyelakin Y, et al
    Genome-Wide Association Study Identifies Genetic Loci for Antibody Response to SARS-CoV-2 Vaccines in Patients With Systemic Autoimmune Diseases and Healthy Individuals.
    J Rheumatol. 2026 Feb 1:jrheum.2025-0770. doi: 10.3899/jrheum.2025-0770.
    PubMed         Abstract available
    
    
28. FORNARO M, Lacedonia D, Cavagna L, Airo P, et al
    Prognostic and Functional Trajectories in Idiopathic Pulmonary Fibrosis and Systemic Autoimmune Rheumatic Disease-Associated Interstitial Lung Disease: Insights From an Italian Multicenter Cohort.
    J Rheumatol. 2026 Feb 1:jrheum.2025-0610. doi: 10.3899/jrheum.2025-0610.
    PubMed         Abstract available
    
    

    
    Mult Scler

29. DI ANTONIO F, Brichetto G, Tacchino A, Pedulla L, et al
    Patient-reported outcomes as predictors of disability evolution in Multiple Sclerosis: An interpretable machine learning approach.
    Mult Scler. 2026 Jan 30:13524585251411093. doi: 10.1177/13524585251411093.
    PubMed         Abstract available
    
    
30. BOLLO L, Pareto D, Tagliani P, Sceppacuercia S, et al
    Optic nerve imaging with OCT predicts disease progression and monitors brain and spinal atrophy in primary progressive multiple sclerosis.
    Mult Scler. 2026 Jan 30:13524585251407976. doi: 10.1177/13524585251407976.
    PubMed         Abstract available
    
    

    
    Neurology

31. VAN NEDERPELT DR, Bos L, Mattiesing RM, Strijbis EM, et al
    Multiple Sclerosis-Specific Reference Curves for Brain Volumes to Explain Disease Severity.
    Neurology. 2026;106:e214694.
    PubMed        
    
    
32. PARAMASIVAN NK, Basal E, LaFrance-Corey RG, Arlt FA, et al
    Clinical Insights Into CASPR1 and CASPR1/Contactin-1 Complex Autoimmune Nodopathies.
    Neurology. 2026;106:e214403.
    PubMed         Abstract available
    
    

    
    PLoS One

33. HOWREN A, Tran QL, Sediqi S, Hawa S, et al
    Effect of race and sex on lupus diagnosis in primary care: A randomized factorial survey study.
    PLoS One. 2026;21:e0342328.
    PubMed         Abstract available
    
    
34. SIKET M, Kovacs L, Eigner G
    Stochastic virtual population in type 1 diabetes.
    PLoS One. 2026;21:e0341034.
    PubMed         Abstract available
    
    
35. AHABWENKI R, Piloya T, Namiiro F, Muzeyi W, et al
    Impact of COVID-19 on New - onset Type 1 diabetes mellitus: A six-year retrospective review from two Paediatric clinics, Kampala, Uganda.
    PLoS One. 2026;21:e0341145.
    PubMed         Abstract available
    
    
36. XUE H, Li B, Wang X, Zhao J, et al
    Performance evaluation and reference interval establishment of Abbott Alinity thyroid-stimulating hormone receptor antibody (TRAb) assay for diagnosing Graves' disease.
    PLoS One. 2026;21:e0339494.
    PubMed         Abstract available
    
    
37. BIAN L, Yang C, Jin Y, Wang H, et al
    Association between carbohydrate quality and glycemic control in individuals with type 1 diabetes: A cross-sectional and meal-based analysis.
    PLoS One. 2026;21:e0341915.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

38. SONG Y, Huang X, Wei L, Shen W, et al
    TRIM21enhances IL-17A signaling and drives autoimmune myocarditis by promoting TRAF3 lysosomaldegradation in cardiac fibroblasts.
    Proc Natl Acad Sci U S A. 2026;123:e2426265123.
    PubMed         Abstract available
    
    
39. OLCHANYI MD, Schreier DR, Li J, Maffei C, et al
    Probabilistic mapping and automated segmentation of human brainstem white matter bundles.
    Proc Natl Acad Sci U S A. 2026;123:e2509321123.
    PubMed         Abstract available
    
    
40. 
    Correction for Curtis et al., Fragmentation signatures in cancer patients resemble those of patients with vascular or autoimmune diseases.
    Proc Natl Acad Sci U S A. 2026;123:e2538063123.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum